Background: When an immune cell migrates from the bloodstream to a site of
| INTRODUCTION
Hypoxia is a common microenvironmental feature of inflamed tissues due to increased oxygen consumption, decreased blood flow, or a combination of both. 1, 2 Hypoxia activates an adaptive cellular transcriptional response driven by the hypoxia-inducible factor (HIF). [3] [4] [5] [6] HIF is a heterodimeric transcription factor formed by the association of oxygen-sensitive HIF-α subunits and a constitutively expressed HIF-1β subunit. HIF-α subunits are synthesized at a high level in all cells but in the presence of oxygen are hydroxylated by three HIFprolyl hydroxylases (PHD1-3) on proline residues marking them for ubiquitination by the von Hipple-Lindau E3 ligase complex and proteosomal degradation. [5] [6] [7] A further hydroxylation of an asparagine residue within the HIF-α transactivation domain blocks its interaction with the CBP/p300 transcriptional co-activator. 4, 8 As well as conferring oxygen dependence on HIF, HIF hydroxylases have been implicated in the regulation of other inflammatory and fibrotic pathways including nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK). [9] [10] [11] [12] [13] [14] Pharmacologic HIF hydroxylase inhibition has been reported to have beneficial effects in various in vivo models of inflammatory disease including colitis and chronic kidney disease. 9, 15, 16 Furthermore, this pathway has been implicated in contact hypersensitivity to nickel, in allergy to UVB light, and in the regulation of T cell-mediated responses. [17] [18] [19] [20] [21] Therefore, manipulation of the HIF pathway represents a potential strategy for the development of anti-inflammatory drugs. Little is known about the potential of therapeutic application of hydroxylase inhibitors in T cell-driven inflammatory skin disorders.
Allergic contact dermatitis (ACD) is a T cell-mediated inflammatory
reaction to epidermal sensitization that causes an over-activation of the immune response upon repeated exposure to the sensitizing hapten. 22, 23 This allergic reaction involves an initial sensitization phase that leads to an elicitation or inflammatory phase. [24] [25] [26] Current therapy for ACD is limited to treatment of the inflammatory episodes with anti-inflammatory agents such as corticosteroids. 24, 27 However, longterm systemic or topical treatment with glucocorticoids can result in severe side effects and recalcitrant cases are difficult to treat.
Because of its efficacy in the treatment of inflammation associated with colitis (which shares several key features with ACD), in this study we investigated whether the protective effects of pharmacologic hydroxylase inhibition extend to allergic skin inflammation. Of note, the protective effects of hydroxylase inhibition in the gut are largely through the enhancement of epithelial barrier function. 2, 11 We report anti-inflammatory actions of hydroxylase inhibitors in allergic skin inflammation mediated through the regulation of chemokine production.
Of note, the two hydroxylase inhibitors used in our study, DMOG and JNJ1935, showed similar effects on granulocyte infiltration. JNJ1935 is a more potent and PHD selective inhibitor than DMOG. 64 A number of other hydroxylase inhibitors are currently in advanced clinical trials for the treatment of chronic kidney disease-associated anemia and have been shown in pre-clinical studies to be effective in the treatment of inflammatory bowel disease (IBD). [10] [11] [12] [13] [14] [15] [16] Hydroxylase inhibitors are currently under advanced clinical investigation for the treatment of anemia making potential repurposing these compounds for other therapeutic applications such as allergic skin disorders a realistic short-to medium-term possibility. 
| Primary human Keratinocytes
Human primary adult keratinocytes were isolated from human donor surplus skin after plastic surgery. Cells from 8 different donors were (HRE) as previously described. 30 Transfection was achieved using lipofectamine 3000 ® (Roche, Penzberg, Upper Bavaria, Germany) following manufacturer's indications.
| Neutrophil apoptosis
Cells were stimulated with 1 μmol/L all-trans retinoic acid (ATRA) to induce differentiation into neutrophils. Neutrophils were then treated with 1 mmol/L DMOG and samples collected at 2, 4, 8, and 24 hours and caspase 3/7 activity was measured.
| Histology
For histology, tissue was formalin-fixed and paraffin-embedded; 4μm sections were cut from paraffin-embedded tissues using a microtome (Leica, Wtzlar, Germany). Tissues were stained with
Pharmacologic inhibition of HIF-hydroxylases, which mimics hypoxia, reduces inflammation in a mouse model of acute contact dermatitis. HIFhydroxylase inhibition reduces inflammatory chemokine production by keratinocytes. Topical application of HIF-hydroxylase inhibitors may be an effective approach for the treatment of T-cell driven allergic skin inflammation.
hematoxylin and eosin and imaged at 20X using the aperio Scanscope console (Leica). For the analysis of T cells, sections were stained with anti-CD3 using Alexa Flour 568 secondary antibody.
For the study of neutrophilic infiltration, sections were co-stained for Ly6G and CXCR2 using Alexa Fluor 488 and 568 secondary antibodies, respectively; 4′, 6-diamidino-2-phenylindole (DAPI) was used for nuclear counterstaining. Images at 20X, 40X, or 100X magnifications were obtained using a fluorescent microscope. was used for all statistical analysis. One-way ANOVA followed by a Newman-Keuls post-test was used for the comparison of multiple groups. Student's t test was used for individual group comparisons.
CD3-or
Differences were considered statistically significant when the P-value was ≤0.05. There was a minimum of three experimental replicates per group.
| RESULTS

| Hydroxylase inhibition reduces inflammation in allergic contact dermatitis
Histologic analysis of DNFB-sensitized mouse ear crosssections revealed an increase in ear thickness following secondary DNFB challenge which was attenuated by DMOG treatment ( Figure 1A ,B).
CXCL1 and CCL5 drive DNFB-induced dermatitis. 22 
| DNFB-mediated inflammation induces transcriptional reprogramming of HIF hydroxylase expression
We next investigated the expression pattern of PHD1-3 in mouse ears. PHD1 was robustly expressed and did not differ in expression levels between vehicle-and DNFB-challenged ears (Figure 2A ,B). Neutrophils also play a central role in DNFB-induced dermatitis. 22, 32 CXCL1 is the key chemokine involved in the recruitment of neutrophils via activation of the CXCR2 receptor. [37] [38] [39] Since CXCL1
protein and RNA expression were reduced by hydroxylase inhibition, we next investigated its impact on DNFB-mediated neutrophil infiltration. Mouse ear cross sections were co-stained for the neutrophil DNFB dramatically increased MPO levels compared to vehicle reflecting increased numbers of neutrophils ( Figure 3H ). In contrast, mice treated with JNJ1935 had significantly lower MPO values confirming its inhibitory effect on neutrophil-mediated DNFB-induced inflammation ( Figure 3H ). In addition to the effects detected on neutrophils, we also analyzed the effect of hydroxylase inhibitors on eosinophils. We found that eosinophils were significantly increased in the ears of DNFB-sensitized and DNFB-challenged mice ( Figure S2 ). This DFNBinduced increase in eosinophil numbers was inhibited in DMOG or JNJ1935 mice ( Figure S2 ).
In order to extend our analysis of inflammatory infiltrates, we also investigated whether hydroxylase inhibitors affect mast cell infiltration. Mast cells were increased in the dermis of mice challenged with DNFB after sensitization but were not reduced by hydroxylase inhibition ( Figure S2 ). Thus, our data indicate that hydroxylase inhibitors selectively affect eosinophil and neutrophil but not lymphocyte or mast cell infiltration in murine ACD.
Together, these results demonstrate that the anti-inflammatory effect of hydroxylase inhibitors in DNFB-induced dermatitis is associated with reduced neutrophil (but not T cell) infiltration into the inflamed tissue.
| Hydroxylase inhibition reduces chemokine production in human primary keratinocytes
Keratinocytes play an important role in skin inflammatory diseases through secretion of chemokines and cytokines which recruit ). H, ELISA of mouse MPO from ear homogenates of mice treated as described in F(n = 4). *means P ≤ 0.05; **means P ≤ 0.01; ***means P ≤ 0.001 neutrophils and activate downstream inflammatory pathways. 40 In ACD, keratinocytes both respond to and express TNF-α. 24 In our experiments, sensitized mice challenged with DNFB expressed increased levels of TNF-α mRNA which were not affected by hydroxylase inhibition ( Figure 4A ). In vitro stimulation of primary human keratinocytes with TNF-α led to the production of a range of cytokines and chemokines including CXCL1, IL-8, and CCL5
( Figure S3 ). 41 
| TNF-α-mediated JNK phosphorylation is reduced by hydroxylase inhibition
The production of inflammatory chemokines in response to DNFB is controlled by the NF-κB and MAPK pathways. 24, 42 We next investigated whether the anti-inflammatory effects of hydroxylase inhibition were due to the blockade of MAPK/NF-κB pathways. Using TNF-induced CCL5
expression as a readout, we compared the effects of JNJ1935 to that of inhibitors of the NF-κB, ERK, JNK, and p38 pathways. As previously Etoposide was used as apoptotic control. E, Scheme indicating the potential multifactor mechanism whereby hydroxylase inhibition reduces chemokine production in keratinocytes while it increases apoptosis in neutrophils. **means P ≤ 0.01; ***means P ≤ 0.001
shown, JNJ1935 reduced CCL5 secretion ( Figure 5A) . Only, the JNK inhibitor SP600125 caused a significant reduction of TNF-α-mediated CCL5 production ( Figure 5A ). Furthermore, TNF-α transiently increased JNK phosphorylation peaking at 0.5 and 2 hours after stimulation in a manner that was attenuated by JNJ1935 treatment (Figure 5B,C) .
Another possible mechanism whereby hydroxylase inhibition could reduce neutrophil infiltration is by triggering apoptotic cell death. In order to investigate this, we used HL60 cells. As seen in Figure 5D , we found DMOG to induce activation of caspase 3/7 in a time-dependent manner. This pro-apoptotic action was comparable to that induced by the positive control etoposide. Therefore, in addition to reducing JNKmediated chemokine production, hydroxylase inhibitors also increase neutrophil apoptosis ( Figure 5E ). From these data, we hypothesize that the anti-inflammatory effects of hydroxylase inhibition are mediated at least in part through attenuation of the JNK pathway in this model and the induction of neutrophil apoptosis.
| Topical administration of DMOG prevents DNFB-mediated neutrophil infiltration
Intraperitoneal administration of hydroxylase inhibitors may cause erythropoiesis. We next investigated whether topical application of the hydroxylase inhibitor DMOG has anti-inflammatory actions in DNFBtreated mice. Hemotoxylin and eosin (H&E) staining and 
| DISCUSSION
In this study, we investigated the impact of hydroxylase inhibitors on allergic skin inflammation.
Inflammatory skin disorders including AD, psoriasis, or ACD are common dermatological diseases, and thus, improved therapies with high efficacy and a low side effect profile are still an unmet clinical need. 24, 43 ACD is caused by a severe inflammatory response upon contact with a hapten to which an individual has become sensitized.
Hapten challenge triggers a multistep inflammatory response in which T cells and neutrophils are key effectors. 22, 25 This response is orchestrated by the release of cytokines and chemokines leading to further inflammation and tissue edema. The DNFB model of ACD is a common model for the study of allergic skin inflammation. 24, 25 Challenge of mouse ears of DNFB-sensitized mice induced a severe inflammatory reaction with formation of edema in the dermis. Dermal edema was accompanied by an increase in CXCL1 and CCL5
expression. These chemokines are crucial for the recruitment of neutrophils and T lymphocytes, respectively. [44] [45] [46] Intraperitoneal treatment with hydroxylase inhibitors reduced ear edema in a manner, which was associated with diminished expression and release of CXCL1 and CCL5. In addition, DNFB-induced inflammation differentially regulated the expression of oxygen-sensing hydroxylases.
Firstly, our studies showed that PHD2 was downregulated in DNFBchallenged skin. PHD-2 is the predominant PHD isoform expressed throughout the body, and its suppression is sufficient to stabilize HIF-α. 47 The downregulation of PHD2 has been purposed as a mechanism of regulation of the HIF pathway mediated by different proinflammatory stimuli. 34, 35 In line with this evidence, our studies showed that DNFB is capable of increasing the expression of the HIF target gene Glut1. This further indicates that DNFB-induced inflammation is related to the establishment of a hypoxic response and modulation of the HIF pathway. This supports the concept that the HIF pathway plays an active role in allergic skin disease.
T cells are key drivers of the allergic response that governs DNFB-mediated inflammation. 22, 48, 49 In our studies, the expression of CD4 was not detected 24 hours after challenge in mouse ears. In contrast, CD8 and GZMB were significantly upregulated at the challenged site suggesting a predominance of CD8+ T cells. Hydroxylase inhibitors did not affect the expression of T cell markers investigated, suggesting that the anti-inflammatory properties of the drugs are not through reducing lymphocyte recruitment. Multiple studies have described the role of CXCL1-mediated neutrophil recruitment in the initiation stages of DNFB-induced ACD. 32, 46, 50 Importantly, the presence of neutrophils is central to the establishment of the T cellmediated response that regulates contact hypersensitivity, highlighting the importance of neutrophils in ACD. 22, 51 Mice sensitized and challenged with DNFB had a large amount of infiltrating Ly6G/ CXCR2-positive neutrophils in the dermis. CXCR2 is the main receptor responsible for CXCL1-dependent recruitment of neutrophils. 37 Studies using models of arthritis have highlighted the importance of this axis. In these studies, blockade of CXCR2 as well as knock out of CXCL1 had anti-inflammatory effects through reduced neutrophil recruitment. 37, 52 In the context of skin inflammation, CXCR2−/− mice were protected against DNFB-induced dermatitis through reduced recruitment of polymorphonuclear cells, whereas other studies correlate reduced CXCL1 with reduced inflammation. 38, 50 In line with this evidence, hydroxylase inhibitor-mediated reduction of CXCL1 expression and secretion was associated with a reduction of neutrophil infiltration, confirming a repression of the CXCL1-induced neutrophil response during acute ACD. Of note, we also found similar effects of hydroxylase inhibitors on eosinophils, indicating that the effects on neutrophils might be extended to other granulocyte populations.
Beyond the formation of physical barriers, the active role of epithelial cells in inflammatory diseases is well documented. 7, 50, [53] [54] [55] In 
| 763
HIF1α mice to infection was due to decreased production of CXCL1 and increased neutrophil apoptosis, resulting in decreased neutrophil infiltration. 60 For instance, hydroxylase inhibition might regulate chemokine production causing inhibition of proinflammatory immune responses.
Several authors have implicated oxygen-sensing hydroxylases in the regulation of inflammatory cell survival. Of note, Walmsley and colleagues described a key role of PHD3 in the induction of neutrophil survival in vitro and in vivo. 36 Given the increased expression of PHD3 in DNFB-challenged skin found in our studies, we investigated whether hydroxylase inhibitors induced neutrophil apoptosis. In line with a role for hydroxylases in the regulation of neutrophil survival, hydroxylase inhibition with DMOG induced time-dependent cell death in cultured neutrophils. Current therapies for ACD are based on the use of anti-inflammatory drugs such as topical/systemic glucocorticosteroids, or immunomodulating ultraviolet light therapy. [61] [62] [63] However, all therapies are still limited for different reasons, whether as to efficacy in severe cases or due to various side effect profiles (eg, skin atrophy, infections, skin dryness, or increased cancer risk after long-term repeated phototherapy). In addition, glucocorticosteroids can in some cases induce allergic contact dermatitis, 63 and systemic approaches induce harmful, partly irreversible adverse events under long-term therapy.
Here, we have shown for the first time that hydroxylase inhibitors may exert a beneficial effect for the treatment of allergic contact dermatitis and probably other chronic inflammatory skin diseases in which neutrophils and eosinophils are involved.
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